Green D M, Donckerwolcke R, Evans A E, D'Angio G J
Roswell Park Cancer Institute, Buffalo, New York, USA.
Hematol Oncol Clin North Am. 1995 Dec;9(6):1317-27.
Successfully treated patients may be at risk for a variety of organ-specific complications, depending upon the treatment administered. Former patients should be carefully screened for such complications to facilitate early intervention. Additional research is necessary to define more accurately the frequency of these complications, to identify techniques for screening of childhood cancer survivors, and to develop therapeutic regimens of equal efficacy but lower potential for long-term morbidity.
成功接受治疗的患者可能会面临各种器官特异性并发症的风险，这取决于所施行的治疗方法。应仔细筛查曾接受治疗的患者是否存在此类并发症，以便于早期干预。需要进一步开展研究，以更准确地确定这些并发症的发生率，确定儿童癌症幸存者的筛查技术，并制定疗效相当但长期发病可能性较低的治疗方案。
